The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of allele-specific HLA loss of heterozygosity in patients with cancer with driver mutations.
 
Tomasz Sewastianik
Employment - Affini-T Therapeutics; Double Rainbow Biosciences (I); Novartis (I)
Stock and Other Ownership Interests - Affini-T Therapeutics (Inst); Double Rainbow Biosciences (I); Moderna Therapeutics; Novartis (I); Pfizer
Patents, Royalties, Other Intellectual Property - Dana Farber Cancer Hospital
 
Christian Roy
Employment - Affini-T Therapeutics
Stock and Other Ownership Interests - Affini-T Therapeutics
 
Patrick Halvey
Employment - Affini-T Therapeutics
Stock and Other Ownership Interests - Affini-T Therapeutics (Inst)
 
Meagan Montesion
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Aastha Jindal
Employment - Lilly (I); Sigilon Therapeutics (I)
Stock and Other Ownership Interests - Lilly (I)
Travel, Accommodations, Expenses - Lilly (I)
 
Sean Garrity
Employment - Affini-T Therapeutics; Moderna Therapeutics (I)
Stock and Other Ownership Interests - Affini-T Therapeutics; Bluebird Bio; Moderna Therapeutics (I); Takeda
 
Hubert Lam
Employment - Affini-T Therapeutics
Stock and Other Ownership Interests - Affini-T Therapeutics
Travel, Accommodations, Expenses - Affini-T Therapeutics
 
Gary Shapiro
Employment - Affini-T Therapeutics; Alnylam (I)
Leadership - Affini-T Therapeutics (Inst)
Stock and Other Ownership Interests - Affini-T Therapeutics (Inst); Alnylam (I)
Patents, Royalties, Other Intellectual Property - Affini-T Therapeutics (Inst)
 
Markus P. Vallaster
Employment - Affini-T Therapeutics
Stock and Other Ownership Interests - Affini-T Therapeutics
 
Loic Vincent
Employment - Affini-T Therapeutics
Leadership - Alaya.bio
Stock and Other Ownership Interests - Affini-T Therapeutics
Consulting or Advisory Role - Bit.bio
Research Funding - Affini-T Therapeutics
Travel, Accommodations, Expenses - Affini-T Therapeutics
 
Gregory Opiteck
Employment - Affini-T Therapeutics; Allogene Therapeutics
Leadership - Affini-T Therapeutics; Allogene Therapeutics
Stock and Other Ownership Interests - Affini-T Therapeutics; Allogene Therapeutics
Consulting or Advisory Role - Cello Therapeutics; Kyverna Therapeutics
Travel, Accommodations, Expenses - Affini-T Therapeutics; Allogene Therapeutics; Arensia Exploratory Medicine
 
Dirk Nagorsen
Employment - Affini-T Therapeutics
Leadership - Affini-T Therapeutics
Stock and Other Ownership Interests - Affini-T Therapeutics
 
Christopher Austin Klebanoff
Stock and Other Ownership Interests - Achilles Therapeutics; Affini-T Therapeutics; CVS Health; DaVita; Gilead Sciences; Obsidian Therapeutics
Honoraria - Kite, a Gilead company
Consulting or Advisory Role - Achilles Therapeutics; Affini-T Therapeutics; Aleta Biotherapeutics; Bellicum Pharmaceuticals; Bristol-Myers Squibb; Catamaran Bio; Cell Design Labs; G1 Therapeutics; Klus Pharma; Obsidian Therapeutics; Roche/Genentech; Royalty Pharma; RXI Pharmaceuticals; T-Knife
Research Funding - Affini-T Therapeutics; Intima; Kite, a Gilead company (Inst); Lilly (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Patents related FAS dominant receptors and uses in CAR-modified NK cells.; Patents related to TCRs targeting a shared PIK3CA neoantigen.; Patents related to TCRs targeting shared hotspot mutations in KRAS G12D, NRAS Q61R/K/L, and P53 (R175H)